Quarterly Results
IBIO Earnings Forecast
Looking ahead, IBIO remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2026/Q2 project quarter revenue of 25.00K and an EPS of -0.09.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2026 have been Revise Upward by 80%, while EPS estimates have been Revise Upward by 9.62%. For the upcoming Q2 2026, revenue estimates have been adjusted Revise Downward by -24.99% . These revisions correlate with a 171.27% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in IBIO long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
1Y
3Y
5Y
Currency: USD
--
Revenue Estimate-:0
--
EPS Estimate-:0
—
Stock Price0
Revenue Estimates for FY2026
Revise Upward
+80%
In Past 3 Month
EPS Estimates for FY2026
Revise Upward
+9.62%
In Past 3 Month
Unlock the reason behind revisions!
Revenue Estimates for Q2 2026
Revise Downward
-24.99%
In Past 3 Month
Stock Price
Go Up
+171.27%
In Past 3 Month
Earnings Forecast
Revenue
EPS
Currency: USD
Actual
Estimate
Al Analysis
Earnings Surprise Analysis
Revenue
EPS
1Y
3Y
Al Analysis
Earnings Reaction
The chart below shows how IBIO performed 10 days before and after its earnings report, based on data from the past quarters. Typically, IBIO sees a -8.79% change in stock price 10 days leading up to the earnings, and a +31.32% change 10 days following the report. On the earnings day itself, the stock moves by -1.62%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in MAR/2024, the stock changed 3.30% on the day following the earnings release and then changed by 31.32% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
People Also Watch
Frequently Asked Questions
What were the key highlights of IBIO's latest earnings report for FY2024Q3?
IBIO reported its FY2024Q3 earnings on 2024-05-13, showcasing a revenue of 0.00 against an estimate of 0.00, resulting in a 0% surprise. The EPS was -0.71, surpassing the expected 0 by 0% . The stock experienced a -1.62% price change on the earnings day and a 7.03% change over the next five days, reflecting market reactions to the results.
How did IBIO's stock price react after the FY2024Q3 earnings release?
Following IBIO's FY2024Q3 earnings announcement on 2024-05-13, the stock price moved by -1.62% on the day of the release. Over the subsequent five days, it saw a 7.03% change. Historically, IBIO's stock price tends to shift by an average of -8.79% in the 10 days leading up to earnings and +31.32% in the 10 days following, providing insight into potential market.
What are the revenue and EPS estimates for IBIO for 2026/Q2?
For 2026/Q2, analysts estimate IBIO’s annual revenue to reach 25.00K, while the EPS is projected at -0.09. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 80% and EPS estimates Revise Downward by -24.99% over the past three months, indicating analyst expectation in the company’s performance.
How does IBIO's stock price correlate with earnings forecast revisions?
The correlation between IBIO's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2026 were Revise Upward by 80%, while EPS estimates moved Revise Downward by -24.99% . This trend suggests that price dips could present buying opportunities for investors.
What should investors expect from IBIO's next earnings report?
Based on historical trends, IBIO's stock price typically moves by -8.79% in the 10 days before its earnings and +31.32% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of -0.09 and revenue of 25.00K.
What is the sentiment in iBio Inc (IBIO) Q3 2022 Earnings Call Summary?
The earnings call presents mixed signals. The basic financial performance shows significant increases in R&D and G&A expenses, indicating investment but also higher costs. The Q&A reveals a strategic shift in vaccine development, which could be positive, but also delays. The lack of clear timelines and details in management responses raises concerns. A reverse stock split could improve stock perception but may not immediately impact fundamentals. Overall, the sentiment is neutral due to balanced positive and negative factors.